Project
EDO-GLIOBLASTOM (S1001-1066)
Automatically Closed · 2022 until 2024
Hundsberger Thomas, Kern Julia, Müller Fiona
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2022
End Date
2024
Financing
Industry
Labels
other tumors
Brief description/objective
A Phase 1 Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Tinostamustine, a Novel Alkylating and Deacetylase Inhibiting Molecule, as Adjuvant Treatment in Patients with Newly Diagnosed Unmethylated MGMT-promoter Glioblastoma